Cardiovascular effects of atropine in postoperative cardiac patients receiving digoxin for ventricular dysfunction

Area of Science:

• Cardiology
• Pharmacology

Background:

• Digoxin is a key cardiac medication for arrhythmias and inotropic support.
• Its therapeutic actions involve the cholinergic nervous system, which can depress ventricular function.
• The study explored augmenting digoxin's effects by antagonizing its cholinergic pathways.

Purpose of the Study:

• To investigate the impact of atropine, a cholinergic blocker, on the cardiovascular effects of digoxin.
• To determine if blocking digoxin's cholinergic effects can enhance cardiac output in postoperative cardiac patients.

Main Methods:

• Ten postoperative cardiac patients received 1 mg of intravenous atropine.
• Cardiovascular parameters including cardiac output were monitored for 8 hours using ECG and advanced hemodynamic monitoring.
• Statistical analysis was performed to assess changes in cardiovascular metrics.

Main Results:

• A significant increase in cardiac output (CO) was observed within 2 hours post-atropine administration (p < 0.05).
• Cardiac output rose from 5.98 L/min to 6.60 L/min.
• No significant changes were noted in heart rate, systemic vascular resistance, pulmonary artery wedge pressure, or systemic blood pressure.

Conclusions:

• Cholinergic blockade of digoxin with atropine acutely enhances cardiac output in postoperative cardiac patients.
• This strategy may offer a method to improve cardiovascular performance in specific patient groups.
• Further research could explore the sustained effects and broader applications of this intervention.